Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-IMPDH2 Antibody (R1N60)

Catalog #:   RHC92801 Specific References (22) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IF, IHC, IP, WB
Accession: P12268
Overview

Catalog No.

RHC92801

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IF: 1:50-1:200, IHC: 1:50-1:100, IP: 1:20, WB: 1:500-1:1000

Target

IMPDH-II, IMPD 2, IMPD2, IMPDH2, IMPDH 2, Inosine-5'-monophosphate dehydrogenase 2, IMP dehydrogenase 2

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P12268

Applications

IF, IHC, IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1N60

Data Image
  • Immunofluorescence
    Immunocytochemistry analysis of IMPDH2 (green) in Hela using IMPDH2 antibody,and DAPI(blue).
  • Immunohistochemical
    Immunohistochemistry analysis of paraffin-embedded Human breast cancer using IMPDH2 antibody.High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval.
  • Western blot
    Western blot analysis of IMPDH2 in 3T3, mouse liver lysates using IMPDH2 antibody.
  • Western blot
    Western blot analysis of IMPDH2 in Hela, A549, HL-60, U2OS, C6 lysates using IMPDH2 antibody
References

Longitudinal plasma proteome profiling reveals the diversity of biomarkers for diagnosis and cetuximab therapy response of colorectal cancer., PMID:38302471

SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling., PMID:36177032

A recombinant scFv antibody-based fusion protein that targets EGFR associated with IMPDH2 downregulation and its drug conjugate show therapeutic efficacy against esophageal cancer., PMID:35416106

Acute severe autoimmune hepatitis with anti-rods and rings autoantibodies; literature first evidence., PMID:33868616

Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/-L1 directed immune checkpoint inhibition., PMID:33434603

Anti-rod and ring antibodies in patients with chronic hepatitis C using direct-acting antivirals., PMID:32537670

IMP dehydrogenase rod/ring structures in acral melanomas., PMID:31883196

Autoantibodies to cytoplasmic rods and rings in patients with hepatitis C virus infection treated with direct-acting antivirals: The role of prior treatment with interferon plus ribavirin., PMID:30446175

Autoantibodies against "rods and rings"-related IMPDH2 in hepatitis C genotype 1 and DAA therapy in a "real life" cohort., PMID:28815296

Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting., PMID:26909861

Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy., PMID:26877604

Anti-rods/rings: a human model of drug-induced autoantibody generation., PMID:25699057

Microinjection of specific anti-IMPDH2 antibodies induces disassembly of cytoplasmic rods/rings that are primarily stationary and stable structures., PMID:25601894

Induction of cytoplasmic pattern in the form of "rods and rings" through the treatment of hepatitis C: a case report., PMID:25476473

Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α., PMID:24845459

Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection., PMID:23506439

Development of a recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies against "rings and rods"-associated inosine-5'-monophosphate dehydrogenase 2 in viral hepatitis C., PMID:23333419

Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients., PMID:23100146

Autoantibodies against inosine-5'-monophosphate dehydrogenase 2--characteristics and prevalence in patients with HCV-infection., PMID:22029192

Lymphocyte counts in kidney allograft recipients are associated with IMPDH2 3757T>C gene polymorphism., PMID:21996196

Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis., PMID:19597826

Mycophenolic acid inhibits oleic acid-induced mesangial cell activation through both cellular reactive oxygen species and inosine monophosphate dehydrogenase 2 pathways., PMID:19093139

Datasheet

Document Download

Anti-IMPDH2 Antibody (R1N60).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-IMPDH2 Antibody (R1N60) [RHC92801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only